Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
格力博
301260
5
拓新藥業
301089
(Q1)2025/03/31 | (FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
營業收入 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
主營業務成本 | ||||||||||
毛利 | ||||||||||
營業費用 | 7.79%2,742.7萬 | -0.67%1.02億 | 7.86%2,594.9萬 | -24.85%2,493.9萬 | 20.69%2,553.7萬 | 5.34%2,544.6萬 | 65.34%1.03億 | 42.96%2,405.8萬 | 91.90%3,318.4萬 | 50.23%2,115.9萬 |
銷售和管理費用 | 26.94%870.7萬 | -18.69%3,175.9萬 | 20.40%794.5萬 | -46.77%977萬 | 2.53%718.5萬 | -3.41%685.9萬 | 74.29%3,906.1萬 | 6.95%659.9萬 | 257.69%1,835.3萬 | 29.25%700.8萬 |
-管理費用 | 26.94%870.7萬 | -18.69%3,175.9萬 | 20.40%794.5萬 | -46.77%977萬 | 2.53%718.5萬 | -3.41%685.9萬 | 74.29%3,906.1萬 | 6.95%659.9萬 | 257.69%1,835.3萬 | 29.25%700.8萬 |
研發費用 | 0.72%1,872萬 | 10.42%7,011.2萬 | 3.12%1,800.4萬 | 2.28%1,516.9萬 | 29.69%1,835.2萬 | 8.98%1,858.7萬 | 60.28%6,349.7萬 | 63.81%1,745.9萬 | 21.96%1,483.1萬 | 63.37%1,415.1萬 |
營業利潤 | -7.79%-2,742.7萬 | 0.67%-1.02億 | -7.86%-2,594.9萬 | 24.85%-2,493.9萬 | -20.69%-2,553.7萬 | -5.34%-2,544.6萬 | -65.34%-1.03億 | -42.96%-2,405.8萬 | -91.90%-3,318.4萬 | -50.23%-2,115.9萬 |
淨非營業利息收入(費用) | 14.49%364.3萬 | 3.01%1,328.9萬 | 24.30%414.3萬 | -11.26%308.8萬 | -15.29%287.6萬 | 18.16%318.2萬 | 511.42%1,290.1萬 | 150.98%333.3萬 | 597.39%348萬 | 1,486.45%339.5萬 |
利息收入 | 14.49%364.3萬 | 3.01%1,328.9萬 | 24.30%414.3萬 | -11.26%308.8萬 | -15.29%287.6萬 | 18.16%318.2萬 | 511.42%1,290.1萬 | 150.98%333.3萬 | 597.39%348萬 | 1,486.45%339.5萬 |
其他淨收入(費用) | -200.00%-3.6萬 | 96.50%-1.1萬 | 119.18%4.7萬 | -540.00%-3.2萬 | 76.67%-1.4萬 | -200.00%-1.2萬 | -361.76%-31.4萬 | -6,025.00%-24.5萬 | 64.29%-5,000 | -11.11%-6萬 |
其他非經營收入(費用) | -200.00%-3.6萬 | 96.50%-1.1萬 | 119.18%4.7萬 | -540.00%-3.2萬 | 76.67%-1.4萬 | -200.00%-1.2萬 | -361.76%-31.4萬 | -6,025.00%-24.5萬 | 64.29%-5,000 | -11.11%-6萬 |
稅前利潤 | -6.93%-2,382萬 | 1.53%-8,859.3萬 | -3.76%-2,175.9萬 | 26.34%-2,188.3萬 | -27.22%-2,267.5萬 | -3.76%-2,227.6萬 | -49.98%-8,997.1萬 | -35.26%-2,097萬 | -76.77%-2,970.9萬 | -28.01%-1,782.4萬 |
所得稅 | -9.28%8.8萬 | 8.79%26萬 | -18.37%4萬 | 6.90%6.2萬 | -15.28%6.1萬 | 61.67%9.7萬 | -33.24%23.9萬 | -84.59%4.9萬 | 346.15%5.8萬 | 1,100.00%7.2萬 |
除稅後利潤 | -6.86%-2,390.8萬 | 1.50%-8,885.3萬 | -3.71%-2,179.9萬 | 26.28%-2,194.5萬 | -27.05%-2,273.6萬 | -3.93%-2,237.3萬 | -49.49%-9,021萬 | -32.85%-2,101.9萬 | -76.97%-2,976.7萬 | -28.47%-1,789.6萬 |
持續經營利潤 | -6.86%-2,390.8萬 | 1.50%-8,885.3萬 | -3.71%-2,179.9萬 | 26.28%-2,194.5萬 | -27.05%-2,273.6萬 | -3.93%-2,237.3萬 | -49.49%-9,021萬 | -32.85%-2,101.9萬 | -76.97%-2,976.7萬 | -28.47%-1,789.6萬 |
歸屬於少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | -6.86%-2,390.8萬 | 1.50%-8,885.3萬 | -3.71%-2,179.9萬 | 26.28%-2,194.5萬 | -27.05%-2,273.6萬 | -3.93%-2,237.3萬 | -49.49%-9,021萬 | -32.85%-2,101.9萬 | -76.97%-2,976.7萬 | -28.47%-1,789.6萬 |
優先股派息 | ||||||||||
其他優先股派息 | ||||||||||
歸屬於普通股股東的淨利潤 | -6.86%-2,390.8萬 | 1.50%-8,885.3萬 | -3.71%-2,179.9萬 | 26.28%-2,194.5萬 | -27.05%-2,273.6萬 | -3.93%-2,237.3萬 | -49.49%-9,021萬 | -32.85%-2,101.9萬 | -76.97%-2,976.7萬 | -28.47%-1,789.6萬 |
基本每股收益 | 13.33%-0.26 | 11.81%-1.12 | 17.24%-0.24 | 33.33%-0.28 | -24.00%-0.31 | 3.23%-0.3 | 23.95%-1.27 | 0.00%-0.29 | 4.55%-0.42 | 54.55%-0.25 |
稀釋每股收益 | 13.33%-0.26 | 11.81%-1.12 | 17.24%-0.24 | 33.33%-0.28 | -24.00%-0.31 | 3.23%-0.3 | 23.95%-1.27 | 0.00%-0.29 | 4.55%-0.42 | 54.55%-0.25 |
每股派息 | ||||||||||
貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
審計意見 | -- | 無保留意見 | -- | -- | -- | -- | 無保留意見 | -- | -- | -- |